A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a robust trade exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Express Worries
However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.
Some experts said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking fines, legal action or prison.
Service Response and Material Elimination
According to TikTok, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The organization said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for preparing or administering at home.
After moments of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Item Details and Pricing
Within these groups, messages show black plastic parcels with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to potentially serious health risks”.
